Clinical Scorecard: Wearable, Physiotherapy-Guided Exercise Combination Could Show Benefit in T2D

At a Glance

Key Highlights

• Intervention group showed a 39-m increase in 6-minute walk distance
• Glycated hemoglobin decreased by 0.89 percentage points in the intervention group
• No adverse events related to the intervention were reported
• Adherence to exercise was feasible with 20 of 25 patients exercising at least three times per week
• No significant difference in estimated glomerular filtration rate between groups

Guideline-Based Recommendations

Diagnosis

• Monitor 6-minute walk distance as a measure of exercise capacity

Management

• Implement physiotherapist-guided exercise with wearable feedback for T2D patients

Monitoring & Follow-up

• Regularly assess glycated hemoglobin and exercise adherence

Risks

• Caution in interpreting renal findings due to potential influence of muscle mass on creatinine estimates

Patient & Prescribing Data

Outpatients with type 2 diabetes and diabetic kidney disease

Combination of physiotherapy and wearable technology improves exercise capacity and metabolic outcomes

Clinical Best Practices

• Encourage gradual increase in physical activity by at least 500 steps above baseline
• Utilize data from wearable devices to tailor exercise plans during physiotherapy sessions
• Monitor for potential adverse events and ensure patient safety during exercise

References

• Diabetology International